MedTrace Logo

Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™

NCT02380092 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2025-12-15

No results posted yet for this study

Summary

LEGION™ Primary Total Knee System is CE-marked and marketed in all study regions. This study serves as post-market surveillance for LEGION™ Primary Total Knee System with the VERILAST™ bearing surface (OXINIUM™ femoral component with highly cross-linked polyethylene tibial insert).

All study subjects will receive a LEGION™ Primary Total Knee System with VERILAST™ bearing surface and the results will be analysed against historical data from patients who received a Genesis II knee replacement.

Conditions

  • Degenerative Joint Disease

Interventions

DEVICE

LEGION™ Primary TKS with VERILAST™ Bearing Surface

All study subjects will be treated with LEGION™ Primary TKS with VERILAST™ Bearing Surface as per standard clinical practice.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Karlie Morgan · Director of Clinical Study Management, Global Clinical Research Operations

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2029-05-31
Completion
2029-05-31

Countries

  • Austria
  • Germany
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380092 on ClinicalTrials.gov